Literature DB >> 3969864

Familial aggregation and early expression of hyperapobetalipoproteinemia.

A Sniderman, B Teng, J Genest, K Cianflone, S Wacholder, P Kwiterovich.   

Abstract

Family history is an important predictor of coronary risk. However, this relation, in large part, is not explained by the known risk factors such as systemic hypertension or hyperlipidemia. In the present study, plasma lipid, lipoprotein lipid, and plasma low-density lipoprotein (LDL) apoB levels were measured in 66 offspring (myocardial infarction [MI] offspring) of 24 families in which an index parent had premature coronary artery disease and hyperapobetalipoproteinemia. These results were compared to those obtained in 207 control children and young adults. Univariate analysis revealed that plasma LDL apoB and all other lipid and lipoprotein levels except high-density lipoprotein cholesterol were significantly higher in the MI offspring. Multivariate analysis showed plasma LDL apoB and LDL cholesterol best differentiated the MI offspring from control children and young adults. Of the 66 children, 22 had hyperapobetalipoproteinemia, of whom only 7 had clearly abnormal LDL cholesterol or plasma triglyceride levels. Thus, a substantial portion of children born to a parent with premature coronary artery disease and hyperapobetalipoproteinemia have the same disorder of lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3969864     DOI: 10.1016/0002-9149(85)90363-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.

Authors:  P N Durrington; L Hunt; M Ishola; J Kane; W P Stephens
Journal:  Br Heart J       Date:  1986-09

2.  Familial combined hyperlipoproteinemia.

Authors:  J Genest
Journal:  CMAJ       Date:  1991-09-15       Impact factor: 8.262

Review 3.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

Review 4.  Genetic influences on susceptibility to atherosclerosis in the young.

Authors:  P O Kwiterovich
Journal:  Bull N Y Acad Med       Date:  1989-12

Review 5.  Treatment of dyslipidemia in children and adolescents.

Authors:  Kathryn Wood Holmes; Peter Oscar Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

6.  Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic.

Authors:  G Pairitz; J Davignon; H Mailloux; C F Sing
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

7.  Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

Authors:  B Teng; A D Sniderman; A K Soutar; G R Thompson
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II.

Authors:  P Kwiterovich; M Motevalli; M Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 9.  Biochemical, clinical, genetic and metabolic studies of hyperapo-beta-lipoproteinaemia.

Authors:  P O Kwiterovich
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

Authors:  M Barbir; D Wile; I Trayner; V R Aber; G R Thompson
Journal:  Br Heart J       Date:  1988-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.